I hereby give my informed consent to receive medical weight loss treatment, including semaglutide, tirzepatide, MIC/B12, glutathione, vitamin C,
glutamine, arginine, L-carnitine, and other wellness support injections, as recommended by the provider.
Semaglutide and tirzepatide are GLP-1 receptor agonist medications used as an adjunct to reduced calorie intake and increased physical activity for
chronic weight management.
While using semaglutide/tirzepatide, it is strongly recommended that you:
● Eat a fibrous diet rich in fruits and vegetables
● Eat small high-protein meals, as digestion may slow down
● Avoid foods high in fat
● Limit alcohol intake
● Drink at least 32 oz of water daily
Do NOT take this medication if:
● You have a personal or family history of medullary thyroid carcinoma (thyroid cancer)
● You have Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
● You are pregnant, breastfeeding, or planning pregnancy
● You are diabetic and take blood sugar-lowering medications without first speaking with your endocrinologist or PCP
● You are prescribed insulin, as the combination may increase your risk of hypoglycemia and dosage adjustments may be necessary
● You have a history of pancreatitis, gallbladder disease, kidney disease, liver disease, or severe cardiac disease
● You are allergic to semaglutide, tirzepatide, or any other GLP-1 agonist medication
● You are currently taking any other GLP-1 medication or weight loss injection, including but not limited to Ozempic, Wegovy, Mounjaro,
Zepbound, Saxenda, Victoza, Trulicity, Rybelsus, Byetta, or any compounded semaglutide/tirzepatide from another source
Possible Side Effects
Possible side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dizziness, bloating, belching, reflux
symptoms, and injection-site reactions including itching, redness, burning, bruising, or swelling.
Serious allergic reactions are rare. Seek immediate medical attention for rash, swelling of the face or throat, severe dizziness, or trouble breathing.
Anti-diabetic agents, including insulin and sulfonylureas, may increase the risk of hypoglycemia. Please disclose all medications and supplements.